AU Patent

AU2018386182B2 — Methods for treating Gaucher disease

Assigned to Genzyme Corp · Expires 2024-03-28 · 2y expired

What this patent protects

Methods for treating Gaucher disease in patients with renal or hepatic impairment.

USPTO Abstract

Methods for treating Gaucher disease in patients with renal or hepatic impairment.

Drugs covered by this patent

eliglustat-tartrate (ELIGLUSTAT TARTRATE)

Patent Metadata

Patent number: AU2018386182B2
Jurisdiction: AU
Classification: —
Expires: 2024-03-28
Drug substance claim: No
Drug product claim: No
Assignee: Genzyme Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.